Literature DB >> 21142383

Impact of preoperative levels of hemoglobin and albumin on the survival of pancreatic carcinoma.

J Ruiz-Tovar1, E Martín-Pérez, M E Fernández-Contreras, M E Reguero-Callejas, C Gamallo-Amat.   

Abstract

INTRODUCTION: Pancreatic cancer presents the worst survival rates of all neoplasms. Surgical resection is the only potentially curative treatment, but is associated with high complication rates and outcome is bad even in those resected cases. Therefore, candidates amenable for resection must be carefully selected. Identification of prognostic factors preoperatively may help to improve the treatment of these patients, focusing on individually management based on the expected response. PATIENTS AND METHODS: We perform a retrospective study of 59 patients with histological diagnosis of pancreatic carcinoma between 1999 and 2003, looking for possible prognostic factors.
RESULTS: We analyze 59 patients, 32 males and 27 females with a mean age of 63.8 years. All the patients were operated, performing palliative surgery in 32% and tumoral resection in 68%, including pancreaticoduodenectomies in 51% and distal pancreatectomy in 17%. Median global survival was 14 months (Range 1-110).We observed that preoperative levels of hemoglobin under 12 g/dl (p = 0.0006) and serum albumina under 2.8 g/dl (p = 0.021) are associated with worse survival.
CONCLUSION: Preoperative levels of hemoglobin and serum albumina may be prognostic indicators in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142383     DOI: 10.4321/s1130-01082010001100003

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  16 in total

1.  A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer.

Authors:  Akira Kawata; Ayumi Taguchi; Satoshi Baba; Yuichiro Miyamoto; Michihiro Tanikawa; Kenbun Sone; Tetsushi Tsuruga; Mayuyo Mori; Katsutoshi Oda; Kei Kawana; Yutaka Osuga; Tomoyuki Fujii
Journal:  Int J Clin Oncol       Date:  2021-01-21       Impact factor: 3.402

2.  Serum protein and electrolyte imbalances are associated with chemotherapy induced neutropenia.

Authors:  Benazir Abbasi; Amjad Hayat; Mark Lyons; Ananya Gupta; Sanjeev Gupta
Journal:  Heliyon       Date:  2022-07-12

3.  Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma.

Authors:  Zhou-Hong Yao; Guang-Yan Tian; Shao-Xiang Yang; Yun-Yan Wan; Yan-Meng Kang; Qing-Hua Liu; Fei Yao; Dian-Jie Lin
Journal:  Tumour Biol       Date:  2014-04-15

4.  Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer.

Authors:  Kun-Chun Chiang; Chun-Nan Yeh; Shir-Hwa Ueng; Jun-Te Hsu; Ta-Sen Yeh; Yi-Yin Jan; Tsann-Long Hwang; Miin-Fu Chen
Journal:  World J Surg Oncol       Date:  2012-05-04       Impact factor: 2.754

5.  Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Aino Salmiheimo; Harri Mustonen; Ulf-Håkan Stenman; Pauli Puolakkainen; Esko Kemppainen; Hanna Seppänen; Caj Haglund
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

6.  Analysis of prognostic factors of patients with malignant peritoneal mesothelioma.

Authors:  Wenjie Yin; Guoqi Zheng; Kunna Yang; Hui Song; Yufei Liang
Journal:  World J Surg Oncol       Date:  2018-03-05       Impact factor: 2.754

7.  CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis.

Authors:  Alessandro Coppola; Vincenzo La Vaccara; Michele Fiore; Tommaso Farolfi; Sara Ramella; Silvia Angeletti; Roberto Coppola; Damiano Caputo
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

8.  Management and survival analysis of elderly patients with a cancer in the digestive system who refused to receive anticancer treatments.

Authors:  Jun Wan; Shiping Xu; Yinqiao Wu; Benyan Wu; Dezhong Joshua Liao; Ningzhi Xu; Gangshi Wang
Journal:  Support Care Cancer       Date:  2018-02-07       Impact factor: 3.603

9.  Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma.

Authors:  Haoran Li; Fang Zhou; Zhifei Cao; Yuchen Tang; Yujie Huang; Ye Li; Bin Yi; Jian Yang; Peng Du; Dongming Zhu; Jian Zhou
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

10.  External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.

Authors:  Dominik Andreas Barth; Carina Brenner; Jakob Michael Riedl; Felix Prinz; Eva Valentina Klocker; Konstantin Schlick; Peter Kornprat; Karoline Lackner; Herbert Stöger; Michael Stotz; Armin Gerger; Martin Pichler
Journal:  Cancer Med       Date:  2020-06-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.